Amazing Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-01-2025
- Paid Up Capital ₹ 0.10 M
as on 02-01-2025
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.21 M
as on 02-01-2025
- Revenue -9.82%
(FY 2022)
- Profit 20.97%
(FY 2022)
- Ebitda 1.25%
(FY 2022)
- Net Worth 22.17%
(FY 2022)
- Total Assets -1.10%
(FY 2022)
About Amazing Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.21 M.
Varadharajan Balasubramanian, Ganesan Sasikumar, and Balaraman serve as directors at the Company.
- CIN/LLPIN
U05000TN2012PTC088650
- Company No.
088650
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Amazing Biotech Private Limited offer?
Amazing Biotech Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed Supplement, Fish Foods, Medical Laboratory Instruments, VTM Kit Raw Materials.
Who are the key members and board of directors at Amazing Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varadharajan Balasubramanian  | Director | 26-Nov-2012 | Current |
| Ganesan Sasikumar | Director | 26-Nov-2012 | Current |
| Balaraman | Additional Director | 11-Nov-2023 | Current |
Financial Performance of Amazing Biotech.
Amazing Biotech Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 9.82% decrease. The company also saw a substantial improvement in profitability, with a 20.97% increase in profit. The company's net worth Soared by an impressive increase of 22.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amazing Biotech?
In 2016, Amazing Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shinebact Biosciences Private LimitedActive 6 years 9 monthsVaradharajan Balasubramanian and Ganesan Sasikumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Feb 2024 | ₹1.02 M | Open |
Hdfc Bank Limited Creation Date: 31 May 2022 | ₹0.59 M | Open |
Hdfc Bank Limited Creation Date: 31 May 2022 | ₹0.59 M | Open |
How Many Employees Work at Amazing Biotech?
Unlock and access historical data on people associated with Amazing Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amazing Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amazing Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
